Eledon Pharmaceuticals, Inc. (ELDN) — 10-Q Filings

All 10-Q filings from Eledon Pharmaceuticals, Inc.. Browse 3 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (3)

  • Eledon Pharma Files Q1 2025 10-Q, Details R&D — May 14, 2025 Risk: medium
    Eledon Pharmaceuticals, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported research and development expenses for the first quarter o
  • Eledon Pharma Files Q3 2024 10-Q — Nov 12, 2024 Risk: medium
    Eledon Pharmaceuticals, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported on its financial condition and results of operations,
  • Eledon Pharmaceuticals Files 10-Q for Period Ending March 31, 2024 — May 15, 2024 Risk: medium
    Eledon Pharmaceuticals, Inc. (ELDN) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Eledon Pharmaceuticals, Inc. filed a 10-Q report for the perio

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.